$CBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST BIOSCIENCES, INC.. Get notifications about new insider transactions in CATALYST BIOSCIENCES, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 24.00 | 257 | 6,168 | 1,153 | 1.4 K to 1.2 K (-18.23 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 257 | 450 | 1,410 | 1.2 K to 1.4 K (+22.29 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 1.75 | 315 | 551 | 41,085 | |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 1.75 | 600 | 1,050 | 41,400 | |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 24.00 | 315 | 7,560 | 7,735 | 8.1 K to 7.7 K (-3.91 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 1.75 | 315 | 551 | 8,050 | 7.7 K to 8.1 K (+4.07 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 24.00 | 600 | 14,400 | 7,735 | 8.3 K to 7.7 K (-7.20 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 1.75 | 600 | 1,050 | 8,335 | 7.7 K to 8.3 K (+7.76 %) |
Apr 22 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.55 | 6,066 | 33,666 | 55,481 | |
Apr 22 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.55 | 2,589 | 14,369 | 0 | |
Apr 22 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.10 | 7,245 | 36,950 | 0 | |
Apr 22 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 23.00 | 15,900 | 365,700 | 7,735 | 23.6 K to 7.7 K (-67.27 %) |
Apr 22 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 5.55 | 8,655 | 48,035 | 23,635 | 15 K to 23.6 K (+57.78 %) |
Apr 22 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 5.10 | 7,245 | 36,950 | 14,980 | 7.7 K to 15 K (+93.67 %) |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.10 | 100 | 510 | 7,245 | |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.10 | 15,744 | 80,294 | 7,345 | |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.10 | 10,750 | 54,825 | 0 | |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.10 | 6,484 | 33,068 | 0 | |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.10 | 3,968 | 20,237 | 0 | |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 23.00 | 100 | 2,300 | 7,735 | 7.8 K to 7.7 K (-1.28 %) |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 5.10 | 100 | 510 | 7,835 | 7.7 K to 7.8 K (+1.29 %) |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 23.02 | 36,946 | 850,371 | 7,735 | 44.7 K to 7.7 K (-82.69 %) |
Apr 20 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 5.10 | 36,946 | 188,425 | 44,681 | 7.7 K to 44.7 K (+477.65 %) |
Apr 02 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | SVP, Lg Affrs, GC a ... | Option Exercise | M | 5.10 | 313 | 1,596 | 0 | |
Apr 02 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | SVP, Lg Affrs, GC a ... | Sell | S | 19.41 | 313 | 6,075 | 0 | 313 to 0 (-100.00 %) |
Apr 02 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | SVP, Lg Affrs, GC a ... | Buy | M | 5.10 | 313 | 1,596 | 313 | 0 to 313 |
Feb 18 2010 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Option Exercise | M | 7.10 | 7,500 | 53,250 | 0 | |
Feb 18 2010 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Option Exercise | M | 9.27 | 7,500 | 69,525 | 17,500 | |
Feb 18 2010 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Sell | S | 19.92 | 15,000 | 298,821 | 0 | 15 K to 0 (-100.00 %) |
Feb 18 2010 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Buy | M | 7.10 | 7,500 | 53,250 | 15,000 | 7.5 K to 15 K (+100.00 %) |
Feb 18 2010 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Buy | M | 9.27 | 7,500 | 69,525 | 7,500 | 0 to 7.5 K |
Jan 21 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | A | 20.68 | 50,000 | 1,034,000 | 50,000 | |
Jan 21 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | A | 20.68 | 50,000 | 1,034,000 | 50,000 | |
Jan 21 2010 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | A | 20.68 | 70,000 | 1,447,600 | 70,000 | |
Jan 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | A | 20.68 | 50,000 | 1,034,000 | 50,000 | |
Jan 21 2010 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | A | 20.68 | 50,000 | 1,034,000 | 50,000 | |
Jan 21 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | A | 20.68 | 40,000 | 827,200 | 40,000 | |
Jan 21 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | A | 20.68 | 40,000 | 827,200 | 40,000 | |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 5.55 | 19,926 | 110,589 | 37,945 | |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 1.75 | 15,975 | 27,956 | 0 | |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 5.10 | 16,049 | 81,850 | 0 | |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 5.10 | 10,750 | 54,825 | 0 | |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 5.10 | 6,456 | 32,926 | 0 | |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 5.10 | 3,952 | 20,155 | 0 | |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 20.51 | 73,108 | 1,499,452 | 0 | 73.1 K to 0 (-100.00 %) |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 5.55 | 19,926 | 110,589 | 73,108 | 53.2 K to 73.1 K (+37.47 %) |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 1.75 | 15,975 | 27,956 | 53,182 | 37.2 K to 53.2 K (+42.94 %) |
Jan 20 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 5.10 | 37,207 | 189,756 | 37,207 | 0 to 37.2 K |
Jan 06 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 20.81 | 7,735 | 160,946 | 0 | 7.7 K to 0 (-100.00 %) |
Jan 05 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.55 | 4,092 | 22,711 | 8,185 | |
Jan 05 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.10 | 312 | 1,591 | 313 | |
Jan 05 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Sell | S | 21.02 | 4,092 | 86,016 | 0 | 4.1 K to 0 (-100.00 %) |
Jan 05 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 5.55 | 4,092 | 22,711 | 4,092 | 0 to 4.1 K |
Jan 05 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Sell | S | 21.30 | 312 | 6,647 | 0 | 312 to 0 (-100.00 %) |
Jan 05 2010 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 5.10 | 312 | 1,591 | 312 | 0 to 312 |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 3.53 | 23,201 | 81,784 | 5 | |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 21.93 | 23,201 | 508,868 | 7,735 | 30.9 K to 7.7 K (-75.00 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 3.53 | 23,201 | 81,784 | 30,936 | 7.7 K to 30.9 K (+299.95 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 124,403 | 217,705 | 0 | |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 75,645 | 132,379 | 28,211 | |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 2,187 | 3,827 | 8,751 | |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 3.53 | 6,769 | 23,861 | 0 | |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 21.98 | 209,004 | 4,593,344 | 0 | 209 K to 0 (-100.00 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 22.99 | 630 | 14,483 | 209,004 | 209.6 K to 209 K (-0.30 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 22.00 | 28,296 | 622,611 | 209,634 | 237.9 K to 209.6 K (-11.89 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 202,235 | 353,911 | 237,930 | 35.7 K to 237.9 K (+566.56 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 3.53 | 6,769 | 23,861 | 35,695 | 28.9 K to 35.7 K (+23.40 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 8.51 | 15,532 | 132,177 | 28,555 | |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 21.93 | 15,532 | 340,663 | 7,735 | 23.3 K to 7.7 K (-66.76 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 8.51 | 15,532 | 132,177 | 23,267 | 7.7 K to 23.3 K (+200.80 %) |
Dec 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 5.10 | 1,000 | 5,100 | 892 | |
Dec 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 5.10 | 11,809 | 60,226 | 1,892 | |
Dec 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 22.27 | 1,000 | 22,269 | 2,799 | 3.8 K to 2.8 K (-26.32 %) |
Dec 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 5.10 | 1,000 | 5,100 | 3,799 | 2.8 K to 3.8 K (+35.73 %) |
Dec 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 22.31 | 11,809 | 263,427 | 2,799 | 14.6 K to 2.8 K (-80.84 %) |
Dec 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 5.10 | 11,809 | 60,226 | 14,608 | 2.8 K to 14.6 K (+421.90 %) |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 21.86 | 22,602 | 494,170 | 1,153 | 23.8 K to 1.2 K (-95.15 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 8.51 | 8,056 | 68,557 | 44,087 | |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 8.51 | 4,967 | 42,269 | 52,143 | |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 2.93 | 7,968 | 23,346 | 34,532 | |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 22.19 | 8,056 | 178,724 | 7,735 | 15.8 K to 7.7 K (-51.02 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 8.51 | 8,056 | 68,557 | 15,791 | 7.7 K to 15.8 K (+104.15 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 22.45 | 4,967 | 111,503 | 7,735 | 12.7 K to 7.7 K (-39.10 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 22.45 | 6,533 | 146,658 | 12,702 | 19.2 K to 12.7 K (-33.96 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 22.44 | 1,435 | 32,206 | 19,235 | 20.7 K to 19.2 K (-6.94 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 8.51 | 4,967 | 42,269 | 20,670 | 15.7 K to 20.7 K (+31.63 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 2.93 | 7,968 | 23,346 | 15,703 | 7.7 K to 15.7 K (+103.01 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 22.28 | 15,391 | 342,922 | 28,926 | 44.3 K to 28.9 K (-34.73 %) |
Dec 16 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 22.44 | 2,600 | 58,340 | 44,317 | 46.9 K to 44.3 K (-5.54 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 13,000 | 22,750 | 0 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 23,255 | 40,696 | 0 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 968 | 1,694 | 0 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 21.53 | 37,223 | 801,262 | 2,799 | 40 K to 2.8 K (-93.01 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 13,000 | 22,750 | 40,022 | 27 K to 40 K (+48.11 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 23,255 | 40,696 | 27,022 | 3.8 K to 27 K (+617.33 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 968 | 1,694 | 3,767 | 2.8 K to 3.8 K (+34.58 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 2.93 | 9,842 | 28,837 | 42,658 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 5.55 | 53,198 | 295,249 | 12,277 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 5.10 | 13,964 | 71,216 | 1,995 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 1.75 | 5,000 | 8,750 | 0 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 5.63 | 1,200 | 6,756 | 0 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 5.10 | 11,555 | 58,931 | 0 | |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Sell | S | 20.90 | 94,759 | 1,980,558 | 0 | 94.8 K to 0 (-100.00 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 2.93 | 9,842 | 28,837 | 94,759 | 84.9 K to 94.8 K (+11.59 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 5.55 | 53,198 | 295,249 | 84,917 | 31.7 K to 84.9 K (+167.72 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 5.10 | 13,964 | 71,216 | 31,719 | 17.8 K to 31.7 K (+78.65 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 1.75 | 5,000 | 8,750 | 17,755 | 12.8 K to 17.8 K (+39.20 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 5.63 | 1,200 | 6,756 | 12,755 | 11.6 K to 12.8 K (+10.39 %) |
Dec 15 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 5.10 | 11,555 | 58,931 | 11,555 | 0 to 11.6 K |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.55 | 6,035 | 33,494 | 12,277 | |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 2.93 | 5,749 | 16,845 | 40,251 | |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.55 | 47,163 | 261,755 | 18,312 | |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.10 | 4,375 | 22,313 | 0 | |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 1.75 | 34,611 | 60,569 | 0 | |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Sell | S | 20.64 | 6,035 | 124,585 | 0 | 6 K to 0 (-100.00 %) |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 5.55 | 6,035 | 33,494 | 6,035 | 0 to 6 K |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Sell | S | 21.00 | 91,898 | 1,930,308 | 0 | 91.9 K to 0 (-100.00 %) |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 5.55 | 47,163 | 261,755 | 91,898 | 44.7 K to 91.9 K (+105.43 %) |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 2.93 | 5,749 | 16,845 | 44,735 | 39 K to 44.7 K (+14.75 %) |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 5.10 | 4,375 | 22,313 | 38,986 | 34.6 K to 39 K (+12.64 %) |
Oct 23 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 1.75 | 34,611 | 60,569 | 34,611 | 0 to 34.6 K |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 1.75 | 7,389 | 12,931 | 34,611 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 1.75 | 5,625 | 9,844 | 0 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 1.75 | 2,333 | 4,083 | 0 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 1.75 | 3,840 | 6,720 | 0 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.63 | 2,560 | 14,400 | 0 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.63 | 995 | 5,597 | 0 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.10 | 908 | 4,631 | 0 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.10 | 1,425 | 7,268 | 908 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | M | 5.10 | 4,375 | 22,313 | 0 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Sell | S | 21.40 | 23,650 | 506,148 | 0 | 23.7 K to 0 (-100.00 %) |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 1.75 | 19,187 | 33,577 | 23,650 | 4.5 K to 23.7 K (+429.91 %) |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 5.63 | 3,555 | 19,997 | 4,463 | 908 to 4.5 K (+391.52 %) |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 5.10 | 908 | 4,631 | 908 | 0 to 908 |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Sell | S | 22.68 | 5,800 | 131,515 | 0 | 5.8 K to 0 (-100.00 %) |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Buy | M | 5.10 | 5,800 | 29,580 | 5,800 | 0 to 5.8 K |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 1.75 | 10,000 | 17,500 | 5,000 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 1.75 | 3,978 | 6,962 | 0 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 1.75 | 5,800 | 10,150 | 3,978 | |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Sell | S | 21.95 | 13,978 | 306,799 | 0 | 14 K to 0 (-100.00 %) |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 1.75 | 13,978 | 24,462 | 13,978 | 0 to 14 K |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Sell | S | 22.68 | 5,800 | 131,515 | 0 | 5.8 K to 0 (-100.00 %) |
Oct 21 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 1.75 | 5,800 | 10,150 | 5,800 | 0 to 5.8 K |
Oct 20 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 23.60 | 374,000 | 8,824,567 | 2,061,925 | 2.4 M to 2.1 M (-15.35 %) |
Oct 20 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 23.60 | 108,000 | 2,548,271 | 2,435,925 | 2.5 M to 2.4 M (-4.25 %) |
Oct 20 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 23.60 | 156,400 | 3,690,274 | 2,543,925 | 2.7 M to 2.5 M (-5.79 %) |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 9,050 | 15,838 | 24,000 | |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 950 | 1,663 | 33,050 | |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 16.27 | 9,050 | 147,226 | 23,755 | 32.8 K to 23.8 K (-27.59 %) |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 9,050 | 15,838 | 32,805 | 23.8 K to 32.8 K (+38.10 %) |